首页 | 本学科首页   官方微博 | 高级检索  
     

辛伐他汀对糖尿病大鼠神经病理性疼痛和全身性炎症的影响及其分子机制
引用本文:张欣,申乐,黄宇光. 辛伐他汀对糖尿病大鼠神经病理性疼痛和全身性炎症的影响及其分子机制[J]. 中国医学科学院学报, 2019, 41(3): 283-290. DOI: 10.3881/j.issn.1000-503X.11140
作者姓名:张欣  申乐  黄宇光
作者单位:中国医学科学院 北京协和医学院 北京协和医院麻醉科,北京 100730
基金项目:国家自然科学基金(81671098)
摘    要:目的 探讨辛伐他汀对糖尿病大鼠神经病理性疼痛及全身性炎症的影响及其机制。方法 采用随机数表法将24只SD大鼠随机分为正常+介质(NV)组、糖尿病+介质(DV)组和糖尿病+辛伐他汀(DS)组3组,每组8只,通过腹腔注射链脲佐菌素建立糖尿病大鼠模型;建模后第7、14、21、28天记录各组大鼠的血糖、体质量、机械性刺激缩足阈值(PWMT)和热刺激缩足反射潜伏期(PWTL);建模后第28天取大鼠腰段脊髓背角和血清,Western blot法检测各组大鼠脊髓背角中晚期糖基化终末产物受体(RAGE)的表达,蛋白激酶B(AKT)、细胞外调节蛋白激酶(ERK)、p38和c-Jun氨基末端激酶(JNK)的磷酸化水平,ELISA法检测各组大鼠血清中氧化型低密度脂蛋白(ox-LDL)和白细胞介素1β(IL-1β)浓度。结果 建模后第14、21、28天,DV组的PWMT值分别为(8.6 ± 0.8)、(7.1 ± 1.6)、(7.8 ± 0.8)g,明显低于NV组的(12.0 ± 0.9)(q =8.482,P =0.000)、(11.6 ± 1.5)(q =11.309,P =0.000)、(11.7 ± 1.5)g(q =9.801,P =0.000);建模后第21、28天,DS组的PWMT值分别为(9.4 ± 1.4)(q =5.780,P=0.000)、(9.7 ± 0.9)g(q =4.775,P=0.003),明显高于DV组。建模后第7、14、21、28天,各组间的PWTL值差异均无统计学意义(P均>0.05)。DV组大鼠脊髓背角中RAGE的表达量明显高于NV组(q =6.299,P =0.000)和DS组(q =2.891,P =0.025);DV组大鼠脊髓背角中AKT磷酸化水平明显高于NV组(q =8.915,P =0.000)和DS组(q =4.103,P =0.003)。DV组大鼠脊髓背角中ERK(q =8.313,P =0.000)、p38蛋白(q =2.965,P=0.022)和JNK(q =7.459,P =0.000)的磷酸化水平明显高于NV组;DS组脊髓背角中JNK的磷酸化水平明显低于DV组(q =3.866,P =0.004),ERK(q =1.987,P =0.122)和p38蛋白的磷酸化水平(q =1.260,P =0.375)与DV组差异无统计学意义。DV组大鼠的血清ox-LDL和IL-1β水平分别为(41.86 ± 13.40)ng/ml和(108.16 ± 25.88)pg/ml,均明显高于NV组的(24.66 ± 7.87)ng/ml(q =3.606,P =0.003)和(49.32 ± 28.35)pg/ml(q =5.079,P =0.000);也明显高于DS组的(18.81 ± 5.62)ng/ml(q =4.833,P =0.000)和(32.73 ± 11.73)pg/ml(q =6.510,P =0.000)。结论 辛伐他汀可在一定程度上提高糖尿病大鼠的机械痛阈,其机制可能与抑制糖尿病大鼠脊髓背角中RAGE/AKT的激活和JNK的磷酸化有关。辛伐他汀还可以显著降低糖尿病大鼠血清中ox-LDL和IL-1β的含量,减轻全身性炎症反应。

关 键 词:糖尿病神经病理性疼痛  辛伐他汀  晚期糖基化终末产物受体  蛋白激酶B  c-Jun氨基末端激酶  氧化型低密度脂蛋白  白细胞介素1β  
收稿时间:2019-01-02

Effects of Simvastatin on Diabetic Neuropathic Pain and Systematic Inflammation in Diabetic Rat Models and Their Molecular Mechanisms
ZHANG Xin,SHEN Le,HUANG Yuguang. Effects of Simvastatin on Diabetic Neuropathic Pain and Systematic Inflammation in Diabetic Rat Models and Their Molecular Mechanisms[J]. Acta Academiae Medicinae Sinicae, 2019, 41(3): 283-290. DOI: 10.3881/j.issn.1000-503X.11140
Authors:ZHANG Xin  SHEN Le  HUANG Yuguang
Affiliation:Department of Anesthesiology,PUMC Hospital,CAMS and PUMC,Beijing 100730,China
Abstract:Objective To investigate the effects of simvastatin on diabetic neuropathic pain and systematic inflammation in diabetic rats and explore their molecular mechanisms.Methods Totally 24 rats were equally randomized into the normal+vehicle(NV)group,diabetic+vehicle(DV)group,and diabetic+simvastatin(DS)group using the random number table.Streptozotocin(STZ)was used to establish the rat models of diabetes.Blood glucose,body mass,paw withdrawal mechanical threshold(PWMT),and paw withdrawal thermal latency(PWTL)in each group were observed on days 7,14,21,and 28 after STZ injection.On day 28 after STZ injection,rats were sacrificed,and the lumbar spinal dorsal horn and serum were collected.Western blotting was used to detect the expression of receptor for advanced glycation end products(RAGE)and the phosphorylation levels of protein kinase B(AKT),extracellular signal-regulated kinase(ERK),p38,and c-Jun N-terminal kinase(JNK)in the spinal dorsal horn of rats in each group.Enzyme-linked immunosorbent assay was performed to determine the serum concentrations of oxidized low density lipoprotein(ox-LDL)and interleukin-1β(IL-1β).Results On days 14,21 and 28 after STZ injection,the PWMT in DV group were(8.6 ± 0.8),(7.1 ± 1.6),and(7.8 ± 0.8)g respectively,which were significantly lower than (12.0 ± 0.9)(q=8.482,P =0.000),(11.6 ± 1.5)(q=11.309,P =0.000),and(11.7 ± 1.5)g(q=9.801,P =0.000)in NV group.The PWMT in DS group on days 21 and 28 were(9.4 ± 1.4)(q=5.780,P =0.000)and(9.7 ± 0.9)g(q=4.775,P =0.003),respectively,which were significantly improved comparing with those of DV group.On days 7,14,21,and 28,there were no significant differences in PWTL among these three groups (all P<0.05).The expression of RAGE in the spinal dorsal horn of DV group was significantly higher than those of NV group(q=6.299,P =0.000)and DS group(q=2.891,P =0.025).The phosphorylation level of AKT in the spinal dorsal horn of DV group was significantly higher than those of NV group(q=8.915,P=0.000)and DS group(q=4.103,P=0.003).The phosphorylation levels of ERK(q =8.313,P=0.000),p38(q =2.965,P =0.022),and JNK(q=7.459,P =0.000)in the spinal dorsal horn of DV group were significantly higher than those of NV group;the phosphorylation level of JNK in the spinal dorsal horn of DS group was significant lower than that of DV group(q=3.866,P =0.004);however,there were no significant differences in the phosphorylation levels of ERK(q=1.987,P=0.122)and p38(q=1.260,P=0.375)in the spinal dorsal horn between DS group and DV group.The serum concentrations of ox-LDL and IL-1β in DV group were(41.86 ± 13.40)ng/ml and(108.16 ± 25.88)pg/ml,respectively,which were significantly higher than those in NV group [(24.66 ± 7.87)ng/ml(q=3.606,P=0.003)and(49.32 ± 28.35)pg/ml(q=5.079,P=0.000)] and DS group [(18.81 ± 5.62)ng/ml (q=4.833,P =0.000)and(32.73 ± 11.73)pg/ml(q=6.510,P =0.000)].Conclusions Simvastatin can relieve the mechanical allodynia of diabetic rats possibly by inhibiting the activation of RAGE/AKT and the phosphorylation of JNK in the spinal dorsal horn.Simvastatin can also decrease the serum concentrations of ox-LDL and IL-1β in diabetic rats,which may contribute to the relief of systematic inflammation.
Keywords:diabetic neuropathic pain  simvastatin  receptor for advanced glycation end products  protein kinase B  c-Jun N-terminal kinase  oxidized low density lipoprotein  interleukin-1β  
点击此处可从《中国医学科学院学报》浏览原始摘要信息
点击此处可从《中国医学科学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号